FI832072A0 - 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner - Google Patents

1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner

Info

Publication number
FI832072A0
FI832072A0 FI832072A FI832072A FI832072A0 FI 832072 A0 FI832072 A0 FI 832072A0 FI 832072 A FI832072 A FI 832072A FI 832072 A FI832072 A FI 832072A FI 832072 A0 FI832072 A0 FI 832072A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI832072A
Other languages
English (en)
Other versions
FI832072L (fi
Inventor
Arnold Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI832072A0 publication Critical patent/FI832072A0/fi
Publication of FI832072L publication Critical patent/FI832072L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI832072A 1982-06-15 1983-06-08 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner FI832072L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15

Publications (2)

Publication Number Publication Date
FI832072A0 true FI832072A0 (fi) 1983-06-08
FI832072L FI832072L (fi) 1983-12-16

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832072A FI832072L (fi) 1982-06-15 1983-06-08 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner

Country Status (19)

Country Link
AU (1) AU1575383A (fi)
BE (1) BE897000A (fi)
CA (1) CA1208639A (fi)
CH (1) CH660593A5 (fi)
DE (1) DE3320616A1 (fi)
DK (1) DK271183A (fi)
ES (2) ES8504179A1 (fi)
FI (1) FI832072L (fi)
FR (1) FR2528431B1 (fi)
GB (1) GB2122192B (fi)
HU (1) HU191853B (fi)
IT (1) IT1178353B (fi)
NL (1) NL8302067A (fi)
NZ (1) NZ204536A (fi)
PH (1) PH23436A (fi)
PT (1) PT76870B (fi)
SE (1) SE8303385L (fi)
WO (1) WO1984000033A1 (fi)
ZA (1) ZA834409B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
AU1570588A (en) * 1987-03-27 1988-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh New intermediate products and process
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
GB2122192B (en) 1985-12-18
AU1575383A (en) 1983-12-22
PT76870A (en) 1983-07-01
PH23436A (en) 1989-08-07
ES538157A0 (es) 1986-02-01
CA1208639A (en) 1986-07-29
ES8604578A1 (es) 1986-02-01
GB2122192A (en) 1984-01-11
ES523243A0 (es) 1985-04-01
PT76870B (en) 1986-02-27
WO1984000033A1 (en) 1984-01-05
FR2528431A1 (fr) 1983-12-16
FR2528431B1 (fr) 1986-01-10
ES8504179A1 (es) 1985-04-01
BE897000A (fr) 1983-12-09
DE3320616A1 (de) 1983-12-15
CH660593A5 (de) 1987-05-15
SE8303385D0 (sv) 1983-06-14
DK271183D0 (da) 1983-06-13
HU191853B (en) 1987-04-28
DK271183A (da) 1983-12-16
IT8348488A0 (it) 1983-06-13
FI832072L (fi) 1983-12-16
SE8303385L (sv) 1983-12-16
ZA834409B (en) 1985-02-27
GB8316054D0 (en) 1983-07-20
NZ204536A (en) 1986-09-10
IT1178353B (it) 1987-09-09
NL8302067A (nl) 1984-01-02

Similar Documents

Publication Publication Date Title
FI810669L (fi) Nya karbostyrilderivat foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI833568A (fi) Nya topiskt applicerbara farmaceutiska kompositioner
FI822005A0 (fi) Antifungisida aemnen, foerfarande foer deras framstaellning, och dessa innehaollande farmaceutiska sammansaettningar
FI833861A0 (fi) Helikromisk-smektiska vaetskekristall kompositioner och displayceller
FI831534A0 (fi) Oxikam-derivat innehaollande farmaceutiska kompositioner och deras framstaellningsfoerfarande
FI820839L (fi) Nya 3,4-dihydro-5h-2,3-benzodiazepinderivat och foerfarande for deras framstaellning
FI822670A0 (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
IT1162879B (it) Composizioni farmaceutiche
DE3382112D1 (de) Pharmazeutische zusammensetzung.
FI830732A0 (fi) Foerfarande foer detektering eller bestaemning av histamin i histaminhaltiga material, isynnerhet kroppsvaetskor, och analytisk anordning foer dylikt foerfarande
FI830959L (fi) Kompositioner foer terapeutisk eller diagnostisk anvaendning och foerfarande foer terapeutisk behandling
FI822386A0 (fi) Indol-tromboxansyntetas-inhibitorer, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
FI832072L (fi) 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI831475L (fi) Nya azepinindoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI833772A (fi) Braennare foer dammformiga, gasformiga och/eller flytande braenslen
FI65673B (fi) Foerfarande och anordning foer detektering av kvistar eller dyikt i saogat virke
FI812190L (fi) Nya pentapeptider foerfaranden foer deras framstaellning farmaceutiska kompositioner innehaollande naemnda pentapeptider och deras anvaendning
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
FI802584A (fi) Nya 1,1,2-trifenylpropan- och propenderivat foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande de nya foereningarna
FI811928L (fi) Nya adeninnukleosidfoereningar deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI792044A (fi) 2-azaergoliner och 2-aza-8 (eller 9)-ergolener
FI793848A (fi) Benzoxadiazoler och benzothiadiazoler deras framstaellning och farmaceutiska kompositioner innehaollande dessa
FI830462L (fi) Mjoeldrygealkaloider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska kompositioner
FI812978L (fi) Nya kefemkompositioner deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG